CARDIOVASCULAR [bdsy]
Markers, Risk [qlco]
treatment [ftcn]
Estradiol [horm, phsu, strd]
trimegestone [orch, phsu]
Dydrogesterone [horm, phsu, strd]
Objective [inpr]
Study [mnob]
CARDIOVASCULAR [bdsy]
Markers, Risk [qlco]
Women [popg]
Take [hlca]
Estradiol [horm, phsu, strd]
trimegestone [orch, phsu]
Estradiol [horm, phsu, strd]
Dydrogesterone [horm, phsu, strd]
Design [acty]
randomized [resa]
prospective [resa]
Double-Blind Study [resa]
Health [idcn]
Post-Menopause [orgf]
Women [popg]
randomized [resa]
Cycle [tmco]
Estradiol [horm, phsu, strd]
mg% [qnco]
trimegestone [orch, phsu]
mg% [qnco]
T-Group [edac]
Estradiol [horm, phsu, strd]
mg% [qnco]
Dydrogesterone [horm, phsu, strd]
mg% [qnco]
Group [idcn]
CARDIOVASCULAR [bdsy]
Markers, Risk [qlco]
Measured [qlco]
Before [tmco]
Cycle [tmco]
4 Weeks [tmco]
post treatment [tmco]
Fibrinogen [aapp, bacs, phsu]
Reduced [qlco]
Group [idcn]
Markedly [qlco]
Group [idcn]
activity levels [fndg]
Decreased [qnco]
Group [idcn]
T-Group [edac]
Factor VII [aapp, bacs, phsu]
Antigen [imft]
Increased [qnco]
Group [idcn]
Group [idcn]
Factor VIIa [aapp, enzy, phsu]
Increased [qnco]
Group [idcn]
Plasminogen [aapp, bacs, phsu]
Levels [qlco]
Increased [qnco]
Group [idcn]
T-Group [edac]
statistically significant [qnco]
Lipid [lipd]
variables [qlco]
regimens [inpr]
Total Cholesterol [lbpr]
Cholesterol, LDL [bacs, strd]
Correlated [qlco]
Group [idcn]
T-Group [edac]
Bleeding [patf]
Pattern [spco]
Conclusions [idcn]
trimegestone [orch, phsu]
Procoagulant [aapp, bacs]
Factor VIIa [aapp, enzy, phsu]
activity [dora]
larger [qnco]
Decrease [qlco]
PAL activity [moft]
Compared [acty]
Dydrogesterone preparation [horm, phsu, strd]
reflect [menp]
Androgen [horm, phsu]
properties [qlco]
trimegestone [orch, phsu]
Preparation [ftcn]
Fibrinogen level [lbpr]
Lp(a) [aapp, bacs]
Decreased [qnco]
Dydrogesterone [horm, phsu, strd]
treatment [ftcn]
Investigation [hlca]
Required [ftcn]
Clarify [acty]
Relative [famg]
effects [qlco]
CARDIOVASCULAR [bdsy]
Published [ocac]
Ireland [geoa]
LTD [ortf]
